Matthew Hayward

Matthew Hayward, PhD, is Vice President of Drug Discovery at Magnet Biomedicine. Matt has over 28 years of experience in the pharmaceutical industry. Prior to joining Magnet, Matt spent 26 years as a medicinal chemist at Pfizer Inc. During his time there, he contributed to the discovery of 8 clinical candidates in the fields of inflammation, neuroscience, immunology, and oncology; penned 30 peer-reviewed publications; and was an inventor on 26 patents. At Pfizer, Matt led the successful Scripps Research collaboration with Professor Benjamin Cravatt and his lab for over a decade, helping to advance the Cravatt lab’s industry leading chemoproteomics platform. Matt is currently the CFO for the Medicinal and Bioorganic Chemistry Foundation, a not-for-profit group established for the arrangement and sponsorship of international conferences, symposia, and educational programs dedicated to the advancement of bioorganic, synthetic, and medicinal chemistry. The foundation runs the popular biennial MBCF conference in Steamboat, Colorado. Matt received his BA from Connecticut College, a PhD in organic chemistry from Yale University, and was an NIH postdoctoral fellow at Harvard University.